Glucosamine vs NMN for blood sugar: which has better evidence?
A tie on evidence grade for blood sugar (Glucosamine Grade — vs NMN Grade —). For blood sugar, the two are evidence-matched; the difference is in effect and safety.
Platform evidence comparison
These existing platform assessments are separate from the source-reported findings below. They do not represent a direct trial comparing these treatments.
| Glucosamine | NMN | |
|---|---|---|
| Grade | safety-flagged | studied, no effect |
| Certainty | low | low |
| Effect | Systematic review (11 studies, 6 RCTs): several studies found DECREASED insulin sensitivity or increased fasting glucose in people taking glucosamine, particularly those with baseline impaired glucose tolerance or insulin resistance. This is a caution signal, not a benefit — people with pre-diabetes or diabetes should be aware glucosamine may worsen glucose metabolism in some studies. | Review of 8 human RCTs (342 mainly non-diabetic middle-age/older adults, 14 days to 12 weeks, 250-2000 mg/day): NMN supplementation showed no significant benefit on fasting glucose, fasting insulin, HbA1c, insulin resistance (HOMA-IR), or lipid profile. Short-term NMN supplementation did not meaningfully improve glucose control in this population. |
| Studied dose | varies across trials | 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials |
| Population | adults, especially those with impaired glucose tolerance or insulin resistance | middle-age/older adults, mainly non-diabetic |
| Safety | 0 modeled interaction(s) | 0 modeled interaction(s) |
Grade or certainty not assigned — evidence bucket does not yet warrant a graded claim.
Direct comparison evidence
There are no direct RCTs in our corpus comparing Glucosamine and NMN head-to-head for blood sugar. What we present above is an indirect comparison: each side's own trials, contrasted. This is standard practice for supplement comparisons — dose, population, and outcome-instrument differences between the two evidence bases add uncertainty on top of each side's own grade.
Can you take both?
No modeled interaction between Glucosamine and NMN in our corpus. Absence of a recorded interaction is not proof of additive benefit — combined-effect trials are usually absent for supplement pairs, so treat "stack" claims skeptically.
Decision guidance
- If certainty matters most — choose whichever side carries the higher certainty rating at a similar grade.
- If you're on medications — check each side's interaction pages before deciding; safety differences dominate small evidence-grade gaps.
- If your population is under-studied — the smaller-effect side with better population evidence often wins over the higher-grade side studied in a different demographic.
- If cost matters — form and dose page differences (Glucosamine vs NMN) can invert the practical winner.
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
Which has stronger evidence: Glucosamine or NMN for blood sugar?
Glucosamine carries Grade — at low certainty; NMN carries Grade — at low. The stronger evidence points to a tie, subject to the caveat that direct head-to-head trials are usually absent for supplement pairings.
Can I take Glucosamine and NMN together?
No modeled interaction between Glucosamine and NMN; combining is not documented to be problematic, but combined-effect trials are also absent, so treat additive benefit claims skeptically.
Have Glucosamine and NMN been compared head-to-head?
Direct RCTs comparing the two for blood sugar are uncommon. This page contrasts each side's own trial evidence — that is an indirect comparison, which introduces confounds from population and dose differences. See the direct-comparison block above.
What decides between Glucosamine and NMN for me?
Read the decision guidance below — the split usually comes down to population fit, interaction risk with your other medications, and how much certainty you want behind the recommendation.
Related
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Glucosamine vs NMN for blood sugar. https://evidencebased.info/compare/glucosamine-vs-nmn-for-blood-sugar. Updated 2026-07-14.
BibTeX
@misc{substrate_nevsnmnforbloodsugar,
author = {Substrate editorial},
title = {Glucosamine vs NMN for blood sugar},
year = {2026},
url = {https://evidencebased.info/compare/glucosamine-vs-nmn-for-blood-sugar},
note = {evidencebased.info}
}